Actively Recruiting
The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia
Led by Istanbul University · Updated on 2026-04-27
40
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this prospective, randomized, controlled, double-blinded study, we aimed to evaluate the effects of Dextrose Prolotherapy injections in patients with coccydynia.
CONDITIONS
Official Title
The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with coccydynia lasting longer than 6 months
- Unresponsive to at least 6 months of conventional conservative treatment methods
- Presence of coccygeal tenderness on palpation
- Age between 18 and 65 years
You will not qualify if you...
- History of trauma within the last 3 months or postpartum coccydynia
- Lesions or infections at the injection site
- Dislocation or organic bone pathology of the coccyx on X-ray imaging
- Fecal or urinary incontinence
- Poorly controlled diabetes mellitus
- History of malignancy
- Bleeding tendency (acquired or hereditary) including INR > 2 for those using warfarin
- History of myelomeningocele
- Diagnosed with spina bifida
- Rheumatologic disease
- Coccyx injection or ganglion block within the last 3 months
- Severe comorbidities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
E
Ekin I Sen, Assoc.Prof.
CONTACT
S
Serhat Yavuz
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here